Tuberculosis miliar con diseminación hematógena posterior a instilaciones de BCG intravesical. Reporte de caso.
A case report : Miliary tuberculosis with hematogenous spread after intravesical BCG instillations
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.
Mostrar biografía de los autores
Miliary tuberculosis after intravesical immunotherapy with bacillus Calmette-Guerin (BCG) is rare. A few systemic complications associated with intravesical BCG instillations have been reported in the literature. In this case report, we present a patient with low-grade urothelial bladder cancer who presented clinical manifestations compatible with tuberculosis 4 hours after the last instillation of BCG as immunotherapy treatment for his bladder cancer. Consequently, a systematic approach was performed, finding micronodular infiltrates of random distribution in thoracic images suggestive of a Miliary pattern. The patient started anti-tuberculous treatment by the decision of an interdisciplinary board. Among the tests carried out, it was found that the endoscopic flexible fiberoptic bronchoscopy did not present alterations, the stains for AFB (acid-fast bacilli) in bronchoalveolar lavage were negative, as was the Gnexpert for Tuberculosis and culture. However, due to the symptoms and relevant risk factors, it was decided to perform wedge resection by thoracoscopy of the middle lobe, revealing a necrotizing granulomatous process whose histological appearance favored infectious etiology. The patient was diagnosed with miliary tuberculosis because of the symptoms presented, compatible radiology, biopsy findings, and clinical improvement in light of the antituberculosis treatment established. This article describes a case of miliary tuberculosis hematogenous spread in a patient who had previously received intravesical BCG instillations for the treatment of urothelial bladder cancer. Prompt treatment saves lives by avoiding a fatal outcome in these patients.
Visitas del artículo 13 | Visitas PDF
Descargas
- Chou , Selph , Buckley DI, Fu , Griffin JC, Grusing , et al. Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis. The Journal of Urology. 2017 May; 197(5). doi: 10.1016/j.juro.2016.12.090
- Sfakianos M.D. JP, Berengere. Bacillus Calmette-Guerin (BCG): Its fight against pathogens and cancer. Urologic Oncology: Seminars and Original Investigations. 2021 Feb; 39 (121-129). DOI: 10.1016/j.urolonc.2020.09.031
- Lobna L, Nesrine , Kaddoussi , Mabrouk , Saoussen Cheikh M, Naceur R. Miliary tuberculosis following intravesical Bacillus Calmette and Guérin therapy: A rare complication of a frequent procedure. Elsevier, Urology Case Reports. 2021; 38(101655) PMCID: PMC8040259 PMID: 33868941
- Steg A, Leleu C, Debré , Boccon-Gibod , Sica. Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer. Prog Clin Biol Res. 1989. PMID: 2672020
- Guallar-Garrido , Julián. Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer: An Update. ImmunoTargets and Therapy. 2020. PMCID: PMC7025668 PMID: 32104666